Go premium today and get access to all the details and pitch decks

FUDZS

Direct Message
Website
Download Pitch Deck
July 20, 2025
Data is self reported
Fudzs is developing a proprietary biomaterial-cellular integration platform that directly addresses the $200+ billion bioproduction market's most pressing challenges: high production costs, resource inefficiency, and scalability limitations.

Achievement

For this startup there is an actual piece of text here instead of this blurred text. It's available to active investors and investors on a paid plan.

Founded in

2023

Country

France

Industry

BioTech, Materials, DeepTech, Health, AgriTech

Patent information

For this startup there is an actual piece of text here instead of this blurred text. It's available to active investors and investors on a paid plan.

Team

Number of founders

Some blurred text here

Number of employees

Founder backgrounds

Exit experience

Some blurred text here

Relevant industry experience

Some blurred text here

Previous startup experience

Some blurred text here

EUR / Erasmus MC or TUDelft relation

Some blurred text here

Graduation year from EUR, Erasmus MC or TUDelft

Some blurred text here

In the news

Investment details

Amount raising

1000000

Ownership founders

Some blurred text here

Lead investor

Some blurred text here

Current investors

Some blurred text here

Intended closing date

Some blurred text here

Fundraising status

Some blurred text here

Already committed

Some blurred text here

Revenue Metrics

Paying customers

Some blurred text here

Monthly active users

Some blurred text here

FUDZS

Direct Message
Download Pitch Deck
July 20, 2025
Data is self reported
Fudzs is developing a proprietary biomaterial-cellular integration platform that directly addresses the $200+ billion bioproduction market's most pressing challenges: high production costs, resource inefficiency, and scalability limitations.

Achievement

We have successfully patented our innovative process and delivered our first product. We are currently developing our state-of-the-art virtual twin bioreactor in collaboration with the 3DS Experience Lab from Dassault Systèmes. This technological advancement will enhance our operational efficiency and product quality. As we strive to maximize our growth trajectory, we are actively exploring new opportunities for expansion and partnerships.

Founded in

2023

Country

France

Province

Industry

BioTech, Materials, DeepTech, Health, AgriTech

SDGs

Good health and well-being (SDG #3), Zero hunger (SDG #2), Climate action (SDG #13), Life below water (SDG #14), Life on land (SDG #15)

Patent information

1 patents and 2 patants ongoing

Team

Number of founders

3

Number of employees

Founder backgrounds

Exit experience

No

Relevant industry experience

Yes

Previous startup experience

Yes

Female founder

Yes

EUR / Erasmus MC or TUDelft relation

Graduation year from EUR, Erasmus MC or TUDelft

In the news

Investment details

Amount raising

1000000

Ownership founders

80-99% owned by founders

Lead investor

2

Current investors

€200000

Intended closing date

Q3, Q4 of this year

Fundraising status

Open for meetings (brand name visible)

Already committed

0

Revenue Metrics

Monthly revenue

pre-revenue

Monthly growth

not growing

Paying customers

0

Monthly active users

10
Fudzs is developing a proprietary biomaterial-cellular integration platform that directly addresses the $200+ billion bioproduction market's most pressing challenges: high production costs, resource inefficiency, and scalability limitations.
Direct MessageSend Message

Premium Details Available

(Data is self reported)

FINANCIAL PERFORMANCE

Monthly Revenue
blurred values
Growth rate month over month
blurred values
Monthly revenue context
blurred values
Number of paying customers
blurred values
Monthly active users
blurred values

INVESTMENTS

Do you have a lead investor?
blurred values
How much have you raised in the past?
blurred values
How much of this round already committed?
blurred values
When are you aiming to close this round?
blurred values

TEAM

How much time do the founders spend on the business?
blurred values
Is there a founder with previous co-founder / c-level at startup experience?
blurred values
Is there a founder with previous Sector Experience?
blurred values
Is there a founder with previous Exit Experience?
blurred values
What percentage of company is owned by founders?
blurred values
Is there a women founder with at least 5% of the shares?
blurred values
Is there a founder with a EUR / Erasmus MC or TUDelft relation?
blurred values
Graduation year from EUR, Erasmus MC or TUDelft
blurred values

OTHER

Year founded
blurred values
Patent status
blurred values
Start your free trial today to explore this information.
Start Free Trial

Premium Details

(Data is self reported)

FINANCIAL PERFORMANCE

Monthly Revenue
pre-revenue
Growth rate month over month
not growing
Monthly revenue context
Number of paying customers
0
Monthly active users
10

INVESTMENTS

Do you have a lead investor?
2
How much have you raised in the past?
€200000
How much of this round already committed?
0
When are you aiming to close this round?
Q3, Q4 of this year

TEAM

How much time do the founders spend on the business?
Is there a founder with previous co-founder / c-level at startup experience?
Yes
Is there a founder with previous Sector Experience?
Yes
Is there a founder with previous Exit Experience?
No
What percentage of company is owned by founders?
80-99% owned by founders
Is there a women founder with at least 5% of the shares?
Yes
Is there a founder with a EUR / Erasmus MC or TUDelft relation?
Graduation year from EUR, Erasmus MC or TUDelft

OTHER

Year founded
2023
Patent status
1 patents and 2 patants ongoing

Basic details

Amount raising
1000000
Country
France
Industry
BioTech, Materials, DeepTech, Health, AgriTech
Founders
linkedin profile of founderlinkedin profile of founderlinkedin profile of founder
Last updated:
July 20, 2025

Key Achievements

  • We have successfully patented our innovative process and delivered our first product. We are currently developing our state-of-the-art virtual twin bioreactor in collaboration with the 3DS Experience Lab from Dassault Systèmes. This technological advancement will enhance our operational efficiency and product quality. As we strive to maximize our growth trajectory, we are actively exploring new opportunities for expansion and partnerships.

Contact this startup to discuss investments

Try it! It's free, no account needed.
This startup has indicated interest to meet with potential investors. If you are interested, please fill out the contact form below and your message will be forwarded to the startup.
Oops! Something went wrong while sending your message.

Provide anonymous feedback

Startups greatly benefit from honest feedback from investors, but rarely receive it for numerous reasons. You can anonymously provide feedback here.
Your name and email address is not shared with the startup, but needed to avoid misusage.
Oops! Something went wrong while sending your message.